42% PMI reduction on a European specialty pharma molecule

Executive summary

A European specialty pharma company approached Operant Scientific with a request to reduce process mass intensity on their existing four-step synthesis of a small-molecule active pharmaceutical ingredient used in a metabolic-condition treatment. The existing route was viable but expensive to run and generated too much solvent waste to meet the client's revised green-chemistry targets.

Our route scouting engagement ran for six months and delivered a three-step biocatalytic alternative that reduced PMI by 42% and cost per kilogram by 33%. The route was validated at bench and pilot scale and cleared EU regulatory review at first submission.

The challenge

The client's original literature-derived route ran four linear steps with a total PMI of approximately 68 — high by modern standards for a small-molecule API. Two of the four steps used a chlorinated solvent for reasons of solubility, and the third-step reagent was a hazardous chloride that required specialised handling and disposal.

The route worked. It had cleared regulatory review in its home market and could produce material to specification. But the cost of goods was creeping up as the chlorinated solvent got harder to source, and the client's parent company had committed to a group-wide PMI reduction target that made the existing route untenable within 18 months.

Approach

We opened the engagement with a full literature and patent-landscape review. Our IP-freedom map showed that two competitor patents constrained certain retrosynthetic disconnections but left substantial open space around a biocatalytic transformation on the second bond. We took that as our starting hypothesis.

Route ideation

The route ideation phase produced four candidate routes, ranging from an incremental modification of the original synthesis to two more radical biocatalytic proposals and one flow-chemistry alternative. Each candidate was scored on our five-axis scorecard.

Selection

Route B scored best on PMI, cost, and timeline. It required a biocatalyst screening exercise before the proof of concept could start, but our enzymatic-catalysis lab had prior experience with the transformation class and we projected a 6-8 week screen with reasonable confidence.

The solution

We ran a focused biocatalyst screen against approximately 40 commercially available enzymes, narrowing to three viable candidates on the basis of conversion and selectivity. The second-round screen then optimised reaction conditions (pH, temperature, cofactor loading, substrate concentration) for the top candidate.

The chosen enzyme delivered the desired transformation with 92% conversion at 20°C in aqueous buffer, replacing what had previously been a chlorinated-solvent step at 80°C using a hazardous chloride reagent. Downstream, the intermediate crystallised cleanly and fed directly into the third and final step of the new synthesis.

Outcome

The new route ran at bench scale, then at 20 L pilot scale, and finally at a 100 kg validation campaign. All three campaigns hit specification on the first attempt. The client submitted the route change to EU regulators through their standard variation process and cleared review without a request for further information.

• Process mass intensity reduced from ~68 to ~39 — a 42% reduction.
• Cost per kilogram reduced by approximately 33%, driven by reagent and solvent cost.
• Chlorinated solvent eliminated from the route entirely.
• EU regulatory variation cleared at first submission, no RFI.
• Total elapsed time from kickoff to validated pilot campaign: 6 months.

Lessons for other buyers

Route scouting engagements pay for themselves quickly when the incumbent route has been in place long enough to accumulate cost bloat. If your route is more than five years old, or if a raw material has been increasing in price without an obvious market reason, it's worth commissioning a scouting engagement even if you're not actively looking to switch.

The IP-freedom map matters as much as the chemistry. Half the value of the engagement was knowing which disconnections were blocked — that saved us from proposing a route that would have run into a competitor's claims six months down the line.